Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

MiCareo

MiCareo?uq=AFYHfsyn
2011 FOUNDED
PRIVATE STATUS
11-20 EMPLOYEES
Accelerator/Inc LATEST DEAL TYPE
1 INVESTORS
Description

Developer of diagnostic tools intended to deliver services for the fundamental unmet needs in rare cell processing for personalized medicine, clinical diagnostics, drug development, and biomarker discovery. The company's diagnostic tools help in performing rare cell isolation and analysis for cancer prognosis, treatment development, efficacy evaluation, clinical diagnosis, drug development and biomarker discovery, enabling researchers to research on disposable microfluidics with sample processing, laser sorting and fluorescence imaging systems for rare cells.

Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Diagnostic Equipment
Primary Office
  • 5F., Number 69, Lane 77, Xing Ai Road
  • Neihu District
  • Taipei City, 114
  • Taiwan

+886 02 0000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore MiCareo’s full profile, request a free trial.

MiCareo Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

MiCareo Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
UW CoMotion Accelerator/Incubator Minority 000 0000 000000 0

MiCareo Executive Team (3)

Name Title Board
Seat
Contact
Info
Jui-Lin Chen Ph.D Chief Executive Officer
Perry Schiro Co-Founder & Chief Technology Officer
Daniel Chiu Co-Founder

MiCareo Board Members (1)

Name Representing Role Since Contact
Info
Hong-Jen Chang MD YFY Biotech Management Company Chairman 000 0000